Donor T-cell responses and disease progression patterns of multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Donor T-cell responses and disease progression patterns of multiple myeloma

Published:2017-10-02 Issue:12 Volume:52 Page:1609-1615
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Eefting M,de Wreede L C,Von dem Borne P A,Halkes C J M,Kersting S,Marijt E W A,Putter H,Veelken H,Schetelig J,Falkenburg J H F

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2017201.pdf

Reference50 articles.

1. Mateos MV, San Miguel JF . How should we treat newly diagnosed multiple myeloma patients? Hematology Am Soc Hematol Educ Program 2013; 2013: 488–495.

2. Moreau P . Death of frontline allo-SCT in myeloma. Blood 2012; 119: 6178–6179.

3. Ahmad I, LeBlanc R, Cohen S, Lachance S, Kiss T, Sauvageau G et al. Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation. Bone Marrow Transplant 2016; 51: 529–535.

4. Lokhorst HM, van der Holt B, Cornelissen JJ, Kersten MJ, van Oers M, Raymakers R et al. Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study. Blood 2012; 119: 6219–6225 quiz 399.

5. Dhakal B, Vesole DH, Hari PN . Allogeneic stem cell transplantation for multiple myeloma: is there a future? Bone Marrow Transplant 2016; 51: 492–500.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor Lymphocyte Infusion to Enhance the Graft-versus-Myeloma Effect;Hemato;2021-04-14

2. Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families;Journal for ImmunoTherapy of Cancer;2019-11-14

3. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma;JCI Insight;2018-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3